CREATION.co work with 24 Pharma clients, including 8 of the top 10, in 38 countries.
CREATION.co delivers actionable insights in more than 56 indications / therapy areas, supporting launch medical or commercial objectives for 101 products.
Find out more
Each identified DOL is featured in a rich profile, to include:
29.09.2023 | Article
eHCP conversation was detected in more than 170 countries discussing type 2 diabetes
By Alexandra Maria Chatziioannidou
29.09.2023 | Article
eHCPs facilitate a broader conversation relating to diabetes - including mental health...
By Aman Jandu
29.09.2023 | Article
There is a significant cluster of highly conversation-connected cardiology specialists
By Francesca Gan
29.09.2023 | Article
In T2D, 13 products have been mentioned more than 100 times by HCPs on social media
By Cameron Bassindale
27.09.2023 | Article
In the lead up to ADA 2023, eHCPs discussed treatments and trials related to DKD
By Cameron Bassindale
Meet the team
Mark Sullivan
Jamie Doggett
Daniel Ghinn
Founder & CEO
20.11.2025 | Whitepaper
Key questions to consider when selecting Digital Opinion Leaders.
03.03.2025 | Article
Setting things straight about HCP Digital Opinion Leaders
By Anni Neumann
23.01.2025 | Article
DOLs are not a paid media channel. Driving authentic trust with Digital Opinion Leaders.
By Daniel Ghinn
13.01.2025 | Article
Learnings from series one of CREATION.co's podcast: Better listening for better health.
By Daniel Ghinn
22.11.2024 | Article
An overview of peer impact in Digital Opinion Leader profiling.
By Katie Kennedy
20.08.2024 | Webinars
Connect with the right DOLs in the right way by understanting their Peer Impact Score...